May 05, 2017
Article
Diabetic patients who received non-invasive shockwave therapy for frozen shoulder had improved range of motion and diminished pain.
February 09, 2017
For patients with HIV, liver disease is a major cause of morbidity and mortality.
January 19, 2017
Glecaprevir is a NS3/4A protease inhibitor and pibrentasvir is a NS5A inhibitor for hepatitis C patients without cirrhosis.
Glecaprevir/pibrentasvir is indicated as an eight-week treatment for hepatitis C among patients without cirrhosis.
August 02, 2016
Zepatier is already approved in the United States and Canada for treatment of hepatitis C.
April 17, 2016
HCV-related deaths continued to rise while deaths from 60 other infectious diseases declined.